| # | Drug | Count |
|---|---|---|
| 0 | DAPAGLIFLOZIN | 205 |
| 1 | METFORMIN | 172 |
| 2 | EMPAGLIFLOZIN | 146 |
| 3 | METFORMIN ER 500 MG | 118 |
| 4 | METFORMIN ER 750 MG | 118 |
| 5 | INSULIN GLARGINE | 89 |
| 6 | LEVETIRACETAM | 65 |
| 7 | LEVETIRACETAM IN SODIUM CHLORIDE | 63 |
| 8 | LEVETIRACETAM INJECTION | 63 |
| 9 | LEVETIRACETAM ORAL | 63 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGZILARGINASE-NBLN | 1 | 0.0323 |
| 1 | TRAVOPROST INTRACAMERAL | 1 | 0.0085 |
| 2 | ERTUGLIFLOZIN | 8 | 0.0072 |
| 3 | MIGLITOL | 6 | 0.0063 |
| 4 | LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE | 1 | 0.0055 |
| 5 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 13 | 0.0037 |
| 6 | DAPAGLIFLOZIN | 205 | 0.0034 |
| 7 | ACARBOSE | 13 | 0.0033 |
| 8 | CLEVIDIPINE | 1 | 0.0027 |
| 9 | DIAZOXIDE | 2 | 0.0027 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | alpha-Glucosidase Inhibitor [EPC] | 19 | 0.0039 |
| 1 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 348 | 0.0032 |
| 2 | Vasopressin Receptor Agonist [EPC] | 1 | 0.0030 |
| 3 | Dopamine-2 Receptor Antagonist [EPC] | 16 | 0.0021 |
| 4 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 1 | 0.0013 |
| 5 | Leptin Analog [EPC] | 1 | 0.0008 |
| 6 | Osmotic Diuretic [EPC] | 3 | 0.0006 |
| 7 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 8 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 15 | 0.0005 |
| 9 | Glinide [EPC] | 4 | 0.0004 |